Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Obama Lawyers Appeal to U.S. High Court for Ruling on Health-Care Overhaul
Bloomberg
Thursday, September 29, 2011 - 9:04am
tags:
healthcare reform, Obama, Supreme Court
Pfizer, pharmacy group warn on counterfeit drugs
Yahoo/AP
Thursday, September 29, 2011 - 9:03am
tags:
Pfizer, drug counterfeiting, Medicines Company
Novo Nordisk's Levemir Gets Support
Yahoo/Zacks.com
Thursday, September 29, 2011 - 9:02am
tags:
Levemir, Novo Nordisk, insulin, type 1 diabetes, Merck, Europe
Analysis: Open-access R&D one answer to drug industry woes
Reuters
Thursday, September 29, 2011 - 8:34am
tags:
R&D, open-access R&D
Merck Pays $1.5M Fine For Pollution Problems
Pharmalot
Thursday, September 29, 2011 - 8:33am
tags:
Merck, pollution
Marshall Edwards Taking Big Pharma Clinical Path
Seeking Alpha
Thursday, September 29, 2011 - 8:32am
tags:
Marshall Edwards, oncology
Merck sells stake in OTC drug venture to J&J unit
Marketwatch
Wednesday, September 28, 2011 - 6:07pm
tags:
OTC, Merck, JNJ, McNeil
Novartis: A Solid Yielding Defensive Play For This Turbulent Market
Seeking Alpha
Wednesday, September 28, 2011 - 6:05pm
tags:
Novartis
Chelsea Therapeutics asks FDA to approve Northera
Yahoo/AP
Wednesday, September 28, 2011 - 12:34pm
tags:
FDA, Northera, Chelsea Therapeutics, Parkinson's Disease
Sequenom Passes This Key Test
Motley Fool
Wednesday, September 28, 2011 - 12:34pm
tags:
Sequenom
Questcor Pharmaceuticals sees Acthar Gel MS prescriptions poised for 3rd-quarter growth
Yahoo/AP
Wednesday, September 28, 2011 - 12:32pm
tags:
Questcor, Acthar, multiple sclerosis, MS
Will Gilead Sciences Blow It Next Quarter?
Motley Fool
Wednesday, September 28, 2011 - 12:32pm
tags:
Gilead
Rexahn Pharmaceuticals advances pancreatic cancer drug
Bizjournals.com
Wednesday, September 28, 2011 - 12:31pm
tags:
Rexahn, pancreatic cancer
Whether Neptune Can Overcome Market Weigh-Down And Deliver On Milestones
Seeking Alpha
Wednesday, September 28, 2011 - 11:45am
tags:
Neptune, China
3 Oversold Biotech Stocks Undervalued By Levered Free Cash Flow
Seeking Alpha
Wednesday, September 28, 2011 - 11:37am
tags:
Momenta, China Biologic, Acadia
Teva exec says Cephalon deal still on track
Philadelphia Inquirer, PA
Wednesday, September 28, 2011 - 11:35am
tags:
Teva Pharmaceuticals, Cephalon, M&A
Nordisk Seeks Approval For Degludec Insulin In Europe And US
NASDAQ.com
Wednesday, September 28, 2011 - 11:33am
tags:
Novo Nordisk, degludec, diabetes, insulin, Europe, FDA
J&J company Ethicon Endo-Surgery buys medical device firm SterilMed for undisclosed terms
Yahoo/AP
Wednesday, September 28, 2011 - 11:32am
tags:
JNJ, Ethicon-Endo Surgery, M&A, SterilMed
Amgen and the Supremes: Did the CEO Know About a Kickback Scheme?
BNET Pharma
Wednesday, September 28, 2011 - 9:21am
tags:
Supreme Court, Amgen, Epogen, Kevin Sharer, kickbacks, Aranesp
Astellas halts development of anti-clotting drug
Reuters
Wednesday, September 28, 2011 - 9:19am
tags:
Astellas, YM150, anti-clotting

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.